If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Shareholding

23 Jul 2015 09:21

RNS Number : 8726T
Scapa Group PLC
23 July 2015
 



 

23 July 2015

 

Scapa Group plc

('Scapa' or 'the Company')

 

 

Director Dealing:

Grant of Options under 2011 Performance Share Plan

and

2015 Save as You Earn Share Option Scheme

 

Scapa, a global manufacturer of bonding materials and solutions for the Healthcare and Industrial markets, announces that it has granted share options to the directors listed below and key members of the management team over a total of 959,039 ordinary shares of 5 pence each in the capital of the Company ('Shares') under the 2011 Performance Share Plan ('PSP'). Options over a further 540,156 Shares have been granted under the 2015 Save As You Earn share option scheme ('SAYE'), which is open to all UK employees of Scapa.

 

Mr Heejae Chae, Group Chief Executive

 

On 22 July 2015, the Company granted options over 192,683 Shares to Mr Chae under the PSP. These options are exercisable between 22 July 2018 and 21 July 2025 at nil cost per Share, subject to achievement of performance criteria. Following this award, Mr Chae holds 2,354,047 options under the PSP.

 

On 22 July 2015, the Company granted options over 5,660 Shares to Mr Chae under the SAYE scheme at an exercise price of 159.0 pence per Share. The SAYE option is exercisable between 1 September 2018 and 28 February 2019, subject to the rules of the scheme. Mr Chae holds 5,660 options under the SAYE scheme.

 

Mr Paul Edwards, Group Finance Director

 

On 22 July 2015, the Company granted options over 117,907 Shares to Mr Edwards under the PSP. These options are exercisable between 22 July 2018 and 21 July 2025 at nil cost per Share, subject to achievement of performance criteria. Following this award, Mr Edwards holds 1,158,223 options under the PSP.

 

On 22 July 2015, the Company granted options over 5,660 Shares to Mr Edwards under the SAYE scheme at an exercise price of 159.0 pence per Share. The SAYE option is exercisable between 1 September 2018 and 28 February 2019, subject to the rules of the scheme. Mr Edwards holds 5,660 options under the SAYE scheme.

 

For further information:

 

Scapa Group plc:

Rebecca Smith +44 (0) 161 301 7400

Company Secretary

 

Numis Securities Limited: +44 (0) 20 7260 1000

Mark Lander

Richard Thomas (Nominated Adviser)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUOAWRVWABURR
Date   Source Headline
1st Mar 201710:22 amRNSAdditional Listing
23rd Feb 201711:03 amRNSHolding(s) in Company
16th Feb 20179:21 amRNSHolding(s) in Company
7th Feb 20174:16 pmRNSBlock listing Interim Review
3rd Feb 20173:53 pmRNSHolding(s) in Company
26th Jan 201710:10 amRNSDirector/PDMR Shareholding
25th Jan 20174:33 pmRNSBlock listing Interim Review
25th Jan 201711:49 amRNSHolding(s) in Company
23rd Jan 20179:18 amRNSDirector/PDMR Shareholding
9th Jan 20179:41 amRNSAdditional Listing
22nd Dec 20162:15 pmRNSAdditional Listing
15th Dec 20167:00 amRNSDirectorate Change
13th Dec 20161:29 pmRNSAdditional Listing
24th Nov 20164:30 pmRNSDirector/PDMR Shareholding
24th Nov 20164:20 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:20 pmRNSAdditional Listing
22nd Nov 20167:00 amRNSHalf-year Report
12th Oct 20167:00 amRNSTrading Statement
27th Sep 20162:53 pmRNSDirector/PDMR Shareholding
21st Sep 20161:51 pmRNSAdditional Listing
6th Sep 201610:24 amRNSAdditional Listing
2nd Sep 201611:20 amRNSBlock listing Interim Review
31st Aug 20169:14 amRNSTotal Voting Rights
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
12th Aug 201611:24 amRNSBlock listing Interim Review
11th Aug 20161:30 pmRNSDirector/PDMR Shareholding
10th Aug 201610:08 amRNSDirector/PDMR Shareholding
19th Jul 20164:58 pmRNSAdditional Listing
19th Jul 20167:00 amRNSAGM Statement
11th Jul 20163:48 pmRNSDirector/PDMR Shareholding
5th Jul 20162:25 pmRNSHolding(s) in Company
1st Jul 20162:58 pmRNSDirector/PDMR Shareholding
1st Jun 20163:49 pmRNSAdditional Listing
1st Jun 20167:00 amRNSAppointment of Joint Broker
24th May 20167:00 amRNSAcquisition
24th May 20167:00 amRNSFinal Results
18th May 201610:01 amRNSAdditional Listing
11th May 201610:45 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSDirectorate Change
14th Apr 20167:00 amRNSTrading Statement
2nd Mar 20169:06 amRNSBlocklisting Interim Review
8th Feb 20169:49 amRNSBlocklisting Interim Review
28th Jan 20167:00 amRNSDirectorate Change
31st Dec 20157:00 amRNSTotal Voting Rights
15th Dec 20159:57 amRNSHolding(s) in Company
14th Dec 20158:26 amRNSHolding(s) in Company
14th Dec 20158:21 amRNSDirector/PDMR Shareholding
8th Dec 201511:46 amRNSHolding(s) in Company
8th Dec 201511:42 amRNSHolding(s) in Company
1st Dec 201510:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.